Alterations in NMDA receptor subunit levels in the brain regions of rats chronically administered typical or atypical antipsychotic drugs

Neurochemical Research

Volumn 28, Issue 6, 2003, Pages 919-924

  Hanaoka, Tadahito ^a   Toyoda, Hirotaka ^a   Mizuno, Takafumi ^a   Kikuyama, Hiroki ^a   Morimoto, Kazushige ^a   Takahata, Ryuichi ^a   Matsumura, Hitoshi ^a   Yoneda, Hiroshi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Antipsychotic drug; Clozapine; Haloperidol; NMDA receptor; Rat brain; Western blotting

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; CLOZAPINE; DRUG ADMINISTRATION SCHEDULE; HALOPERIDOL; INJECTIONS, INTRAPERITONEAL; KINETICS; MALE; ORGAN SPECIFICITY; PROTEIN SUBUNITS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

ANIMALIA;

EID: 0346037249     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023231611616     Document Type: Article

References (35)

1. Moriyoshi, K., Masu, M., Ishii, T., Shigemoto, R., Mizuno, N., and Nakanishi, S. 1991. Molecular cloning and characterization of the rat NMDA receptors. Nature 354:31-37.
2. Meguro, H., Mori, H., Araki, K., et al. 1992. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature 357:70-74.
3. Yamazaki, M., Mori, H., Araki, K., Mori, K., and Mishina, M. 1992. Cloning, expression and modulation of a mouse NMDA receptor subunit. FEBS Lett. 300:39-45.
4. Kutsuwada, T., Kashiwabuchi, N., Mori, H., et al. 1992. Molecular diversity of the NMDA receptor channel. Nature 358:36-41.
5. Monyer, H., Sprengel, R., Schoepfer, R., et al. 1992. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science 256:1217-1221.
6. Ikeda, K., Nagasawa, M., Mori, H., et al. 1992. Cloning and expression of the E4 subunit of the NMDA receptor channel. FEBS Lett. 313:34-38.
7. Ishii, T., Moriyoshi, K., Sugihara, H., et al. 1993. Molecular characterization of the family of N-methyl-D-asparatate receptor subunits. J. Biol. Chem. 268:2836-2843.
8. Javitt, D. C. 1987. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J. Clin. Psychiatry 9:12-35.
9. Javitt, D. C. and Zukin, S. R. 1991. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148: 1301-1308.
10. Johnson, K. M., Snell, L. D., Sacaan, A. I., Jones, S. M. 1989. Pharmacological regulation of the phencyclidine-binding site associated with the N-methyl-D-aspartate receptor operated ion channel. Drug Dev. Res. 17:281-297.
11. Carlsson, M. and Carlsson, A. 1990. Interactions between glutamatergic and monoaminergic systems within the basal ganglia: Implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13:272-277.
12. Toru, M., Watanabe, S., Shibuya, H., et al. 1988. Neurotransmitters, receptors and neuropeptides in post mortem brains of chronic schizophrenic patients. Acta Psychiatr. Scand. 78:121-137.
13. Harrison, P. J., McLaughlin, D., and Kerwin, R. W. 1991. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 337:450-452.
14. Deakin, J. F. W., Slatter, P., Simpson, M. D. C. et al. 1989. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J. Neurochem. 52:1781-1786.
15. Ibrahim, H. M., Hogg, A. J., Jr., Healy, D. J., Haroutunian, V. Davis, K. L., Meador Woodruff J. H. 2000. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am. J. Psychiatry 157:1811-1823.
16. Healy, D. J., Haroutunian, V., Powchik, P., et al. 1998. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics. Neuropsychopharmacology 19:278-286.
17. Kim, J. S., Kornhuber, H. H., Schmid-Burgk, W., and Holzmüller, B. 1980. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 20: 379-382.
18. Kornhuber, J. and Kornhuber, M. E. 1986. Presynaptic dopamine modulation of cortical input to the striatum. Life Sci. 39:669-674.
19. Giorgueff, M. F., Kernel, M. L., and Glowinski, J. 1977. Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices. Neurosci. Lett. 6:73-77.
20. Leviel, V., Gobert, A., and Guibert, B. 1990. The glutamatemediated release of dopamine in the rat striatum: Further characterization of the dual excitatory-inhibitory function. Neuroscience 39:305-312.
21. Krebs, M. F., Desce, J. M., Kemel, M. L., et al. 1991. Glutamatergic control of dopamine release in the rat striatum: Evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic terminals. J. Neurochem. 56:81-85.
22. Micheletti, G., Lannes, B., Warter, J. M., Zwiller, J., Evidence for NMDA/D2 receptor-receptor interactions in the rat striatum. Pages 128-132, in Narabayashi, H., Nagatsu, T., Yanagisawa, N., and Mizuno, Y., (eds.) Advances in Neurology. Vol. 60. Raven Press, New York, NY.
23. Johnstone, E. C., Crow, T. J., Frith, C. D., Carney, M. W. P., and Prince, J. S. 1978. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet 22:848-851.
24. Freed, W. J. 1988. The therapeutic latency of neuroleptic drugs and nonspecific postjunctional supersensitivity. Schizophrenia Bull. 14:269-277.
25. Eastwood, S.L., Story, P., Burnet, P. W. J., Heath, P., and Harrison, P. J. 1994. Differential changes in glutamate receptor subunit messenger RNAs in rat brain after haloperidol treatment. J. Psychopharmacol. 8:196-203.
26. Oretti, R. G., Spurlock, G., Buckland, P. R., and McGuffin, P. 1994. Lack of effect of antipsychotic and antidepressant drugs on glutamate receptor mRNA levels in rat brains. Neurosci. Lett. 177:39-43.
27. Fitzgerald, L. W., Deutch, A. Y., Gasic, G., and Heinemann, S. F., and Nestler. E. J. 1995. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J. Neurosci. 15:2453-2461.
28. Toyoda, H., Takahata, R., Inayama, Y., et al. 1997. Effect of antipsychotic drugs on the gene expression of NMDA receptor subunits in rats. Neurochem. Res. 22:249-252.
29. Riva, M. A., Tascedda, F., Lovati, E., and Racagni, G. 1997. Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs. Brain Res. Mol. Brain Res. 50:136-142.
30. Chen, A. C., McDonald, B., Moss, S. J., and Gurling, H. M. 1998. Gene expression studies of mRNAs encoding the NMDA receptor subunits NMDAR1, NMDAR2A, NMDAR2B, NMDAR2C, and NMDAR2D following long-term treatment with cis-and trans-flupenthixol as a model for understanding the mode of action of schizophrenia drug treatment. Brain Res. Mol. Brain Res. 54:92-100.
31. Tascedda, F., Lovati, E., Blom, J. M., et al. 1999. Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic seroquel (quetiapine fumarate). Neuropsychopharmacology 21:211-217.
32. Kalluri, H. S. G., Mehta, A. K., and Ticku, M. K. 1998. Up-regulation of NMDA receptor subunits in rat brain following chronic ethanol treatment. Mol. Brain Res. 58:221-224.
33. Guitart, X., Mendez, R., Ovalle, S., et al. 2000. Regulation of ionotropic glutamate receptor subunits in different rat brain areas by a preferential sigma (1) receptor ligand and potential atypical antipsychotic. Neuropsychopharmacology 23:539-546.
34. Ilyin, V. I., Whittemore, E. R., Guastella, J., Weber, E., and Woodward, R. M. 1996. Subtype-selective inhibition of N-methylD-aspartate receptors by haloperidol. Mol Pharmacol. 50:1541-1550.
35. Yamakura, T., Sakimura, K., Mishina, M., and Shimoji, K. 1998. Sensitivity of the N-methyl-D-aspartate receptor channel to butyrophenones is dependent on the epsilon2 subunit. Neuropharmacology 37:709-717.